APA (7th ed.) Citation

Peng, Y., Yang, H., Zhu, T., Zhao, M., Deng, Y., Liu, B., . . . Tao, L. (2013). The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. European Journal of Clinical Investigation, 43(4), 358. https://doi.org/10.1111/eci.12053

Chicago Style (17th ed.) Citation

Peng, Yu, et al. "The Antihepatic Fibrotic Effects of Fluorofenidone via MAPK Signalling Pathways." European Journal of Clinical Investigation 43, no. 4 (2013): 358. https://doi.org/10.1111/eci.12053.

MLA (9th ed.) Citation

Peng, Yu, et al. "The Antihepatic Fibrotic Effects of Fluorofenidone via MAPK Signalling Pathways." European Journal of Clinical Investigation, vol. 43, no. 4, 2013, p. 358, https://doi.org/10.1111/eci.12053.